Quantitative assessment of human proteinases as agents for chemonucleolysis

Spine (Phila Pa 1976). 1988 Feb;13(2):188-92. doi: 10.1097/00007632-198802000-00010.

Abstract

A rabbit model system is described. It allows accurate measurement of the dose-dependent loss of glycosaminoglycan from the nucleus pulposus of lumbar intervertebral discs after injection of a proteinase. At the dose equivalent to that of chymopapain used in human chemonucleolysis, two human serine proteinases, cathepsin G and chymotrypsin, were as effective as chymopapain in removing up to 80% of the glycosaminoglycan from the disc. A cysteine proteinase, cathepsin B released no more than 45% of glycosaminoglycan. X-ray films clearly showed narrowing of the disc space when 30-40% of glycosaminoglycan was removed. The degradation of the nucleus pulposus was seen histologically as loss of toluidine blue metachromasia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cathepsin G
  • Cathepsins / therapeutic use*
  • Chymopapain / pharmacology
  • Chymotrypsin / therapeutic use*
  • Endopeptidases / therapeutic use*
  • Glycosaminoglycans / metabolism
  • Humans
  • Intervertebral Disc / diagnostic imaging
  • Intervertebral Disc / metabolism
  • Intervertebral Disc / pathology
  • Intervertebral Disc Chemolysis*
  • Lumbar Vertebrae / diagnostic imaging
  • Lumbar Vertebrae / metabolism
  • Lumbar Vertebrae / pathology
  • Radiography
  • Serine Endopeptidases

Substances

  • Glycosaminoglycans
  • Cathepsins
  • Endopeptidases
  • Serine Endopeptidases
  • Chymotrypsin
  • CTSG protein, human
  • Cathepsin G
  • Chymopapain